Combination of Stereotactic Radiosurgery and Enhanced Immunotherapy for Recurrent Glioblastomas(inSituVac2)(CSREIG)

NCT05131711 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Glioblastoma

Interventions

COMBINATION_PRODUCT: Combined stereotactic radiosurgery and enhanced immunotherapy

Sponsor

Beijing Tiantan Hospital